Home › Funds › WOLVERINE ASSET MANAGEMENT LLC › DMII

WOLVERINE ASSET MANAGEMENT LLC position in DMII

DRUGS MADE IN AMER ACQ II CO · Financials

WOLVERINE ASSET MANAGEMENT LLC reported holding 1,842,235 shares of DMII (DRUGS MADE IN AMER ACQ II CO) in its Q3 2026 13F filing — a position valued at US$18.8M, representing 0.36% of its reported portfolio and ranking #49 among its reported holdings. WOLVERINE ASSET MANAGEMENT LLC has disclosed DMII holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.84M sh
Reported value held$18.75M
Portfolio Weight0.36%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WOLVERINE ASSET MANAGEMENT LLC's DMII position evolved

WOLVERINE ASSET MANAGEMENT LLC first disclosed a stake in DMII in Q4 2025 at 1,062,773 shares (US$10.5M). The position peaked in Q3 2026 at 1,842,235 shares, worth US$18.8M. Across 4 filings, WOLVERINE ASSET MANAGEMENT LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,842,235 shares valued at US$18.8M — a reduction of -12,987 shares quarter over quarter.. Notable position changes include a 69% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.06M $10.52M New
Q1 2026 1.80M $17.90M Add
Q2 2026 1.86M $18.66M Add
Q3 2026 1.84M $18.75M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMII and 13F data

DMII (DRUGS MADE IN AMER ACQ II CO) is a Financials company. 71 other funds we track also report a position in DMII — the largest reported positions include Karpus Management, Inc. (US$28.0M), Magnetar Financial LLC (US$27.5M), MMCAP International Inc. SPC (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMII

All DMII fund holders →

FAQ

How long has WOLVERINE ASSET MANAGEMENT LLC held DMII?

WOLVERINE ASSET MANAGEMENT LLC has disclosed DMII holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is WOLVERINE ASSET MANAGEMENT LLC's current position in DMII?

As of Q3 2026, WOLVERINE ASSET MANAGEMENT LLC holds 1.84M shares of DMII (DRUGS MADE IN AMER ACQ II CO), valued at $18.75M, representing 0.36% of its reported portfolio and ranking #49.

Has WOLVERINE ASSET MANAGEMENT LLC been buying or selling DMII?

In the latest 13F filing (Q3 2026), WOLVERINE ASSET MANAGEMENT LLC reduced its position in DMII. The position peaked in Q3 2026 at 1.84M shares.

Which other funds hold DMII?

Other major institutional holders of DMII include Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.